JW Pharmaceutical Corporation (KRX:001065)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,450
+600 (2.08%)
Feb 25, 2026, 3:30 PM KST
Market Cap844.27B +52.1%
Revenue (ttm)764.21B +3.8%
Net Income57.97B -14.5%
EPS2,508.80 -15.8%
Shares Outn/a
PE Ratio14.56
Forward PEn/a
Dividend525.00 (1.80%)
Ex-Dividend DateMar 31, 2026
Volume184
Average Volume570
Open29,900
Previous Close28,850
Day's Range29,450 - 29,900
52-Week Range26,550 - 30,300
Beta1.12
RSI58.46
Earnings DateMar 13, 2026

About JW Pharmaceutical

JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases , and pancreatic cancer. The company also offers infant care system, gynecological examining table, operating room equipment, steam sterilizer, and other equipment. In addition, it offers wound care, pain care, and beauty care related products. The company was founded in 1945 and is base... [Read more]

Sector Healthcare
Founded 1945
Employees 1,068
Stock Exchange Korea Stock Exchange
Ticker Symbol 001065
Full Company Profile

Financial Performance

In 2024, JW Pharmaceutical's revenue was 719.38 billion, a decrease of -3.89% compared to the previous year's 748.53 billion. Earnings were 60.78 billion, an increase of 64.24%.

Financial Statements